Yossi Dagon
11Patents
3h-index
20Co-inventors
56Inventor score
Filing activity: Sep 14, 2006 → Oct 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11028145B2 | ALK7:actriib heteromultimers and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10501547B2 | ALK7 binding proteins and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10227392B2 | ALK7:ActRIIB heteromultimers and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11059894B2 | ALK7 binding proteins and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10166202B2 | Treatment of hepatic encephalopathy and liver cirrhosis | Emerging Cross-Sectional Technologies | 1 | Active |
| US11708414B2 | ALK7 binding proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12365736B2 | ALK7 binding proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11827689B2 | ALK7:ActRIIB heteromultimers and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11439673B2 | Bacteria engineered to treat liver disease | Human Necessities | 0 | Active |
| US9333240B2 | Compounds for improving nutritional status, cognition and survival | Human Necessities | 0 | Active |
| US12024563B2 | ALK7 antagonists and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.